Your session is about to expire
← Back to Search
Secur-Fit Hip Stem for Hip Replacement
Study Summary
This trial is testing a new hip stem for primary hip arthroplasty. The success rate is expected to be at least 99% at 5 years.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a condition like Lupus or Paget's disease that weakens my bones.I might have an infection in or near my hip where a device will be implanted.I have been diagnosed with a type of arthritis that is not caused by inflammation.I need both of my hips replaced at the same time.I am on long-term steroids or have a weakened immune system.I am willing and able to follow through with all scheduled after-surgery check-ups and rehab.I have had open surgery on my hip before.I have a hip replacement on the opposite side.I am between 21 and 75 years old, not pregnant, and fully grown.I am a candidate for a first-time hip replacement surgery.I had a thigh bone fracture on the side I'm having surgery.
- Group 1: Secur-Fit Advanced
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any more opportunities to join this clinical trial?
"Affirmative. Clinicaltrials.gov confirms that this clinical trial, which commenced on August 1st 2013, is presently recruiting participants; 326 patients are needed from 6 sites."
Is there an opportunity for me to take part in this clinical investigation?
"This clinical trial seeks 326 individuals with non-inflammatory degenerative joint disease and are between 21 to 75 years old. To be accepted, the patient must sign an IRB/EC approved informed consent form, they must not be pregnant females and should have a willingness to comply with postoperative evaluations as well as rehabilitation requirements."
What is the total count of facilities administering this trial?
"The 6 sites for this study span from Tucson to Danville and Albany. To reduce the strain of travelling, it is recommended that potential participants choose a clinic in their vicinity."
What is the cap on participants involved in this research venture?
"Affirmative. The information hosted on clinicaltrials.gov confirms that this study, which was initially posted on August 1st 2013, is actively recruiting participants. Around 326 patients must be recruited from 6 distinct medical sites."
Is the age requirement for this experiment limited to those over 30 years?
"Patients aged 21 to 75 that wish to take part in this trial must meet the inclusion criteria. Additionally, there are two trials for minors and twenty-six options available to seniors over 65 years old."
Share this study with friends
Copy Link
Messenger